Neurodon Corp
Pharmaceutical company · Crown Point, Indiana, United States
Neurodon Corp is a pharmaceutical company headquartered in Crown Point, Indiana, United States. Its earliest recorded incorporation is in 2019. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $3.7 million in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $500,000 sold in a notice filed in 2019.
Neurodon at a glance
What does Neurodon do?
US government research funding
4 SBIR/STTR small-business research awards from US health agencies, $3.7 million in total (2018 to 2023). NIH funding came from the National Institute on Aging, National Institute of Diabetes and Digestive and Kidney Diseases.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $500,000 sold (2019).
Frequently asked questions about Neurodon
Where is Neurodon headquartered?
Neurodon Corp is headquartered in Crown Point, Indiana, United States.
What does Neurodon do?
Neurodon Corp is a pharmaceutical company.
When was Neurodon founded?
The earliest incorporation on record for Neurodon Corp is in 2019, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences